Replies to post #255642 on Biotech Values

[dewophile]

And what part of that says zero?

what part of what I said said you said zero? I said you *implied* zero or negligible

You just re-quoted what I re-quoted in the post you just replied to.

I quoted you and you only check again

if you do the math, 50 cents for a 2+4 cvr isn't showing any enthusiasm, that is showing less than 25% odds of collecting the $2 cvr.

agreed. which when i look back you did mention no enthusiasm for *the cvr*. i took the implication as no enthusiasm for the drug. maybe you were being literal but the implication for most readers (i think) was little enthusiasm for the cvr = little enthusiasm for the drug. again i simply want to point out you dont know what they allocated to the drug based on a sum of parts analysis in the 129 dollars if you did mean little enthusiasm for the drug (which is what matters after all)

[DewDiligence]

BPMC—…50 cents for a 2+4 cvr isn't showing any enthusiasm...

Two points (for the benefit of readers who might not be following this matter closely): 1) The BPMC CVR is non-tradable, which lessens the amount shareholders ascribe to it as compared to a tradable CVR; and 2) Investors have devalued clinical and regulatory CVRs to some degree based on what BMY did to CELG shareholders—i.e. they don’t fully trust Big Pharma to play fair.